Australian CSIRO, GE Health care partner for investigational PET imaging agent Today announced a collaboration with Australian GE Health care Commonwealth Scientific and Industrial Analysis Organisation involving its investigational PET imaging agent [18F flutemetamol] click here . Related StoriesReducing medical center readmissions through Transitional Treatment: an interview with Rani KhetarpalCancer medical diagnosis improvements in England: an interview with Lucy Elliss-BrookesDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of Polyphotonix This collaboration is an integral part of our ongoing work to understand and help recognize Alzheimer’s disease and the consequences of beta amyloid in the brain, stated Pascale Witz, CEO of GE Health care Medical Diagnostics.

He says doctors and nurses who be receiving and dealing with victims of terrorist episodes should be up to day with their understanding of the types of accidents and treatments needed after bomb blasts. Abbott says the bundle includes $80 million to get antivirals and antibiotics, including Relenza and Tamiflu, for the nationwide medical stockpile, and says the risk of a pandemic is certainly real, and can remain a possibility within the next couple of years. Professor Rosenfel’s record is published in today’s problem of the Medical Journal of Australia..